ANIXA BIOSCIENCES INC (ANIX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Ovarian cancer CAR-T therapy, lira-cel, advances to highest dose level to date in fifth cohort with lymphodepletion—four patients surpass one year of survival, longest at approximately 28 months ...
SAN JOSE, Calif., Sept. 9, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...
Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine ...
Presentation to highlight Anixa's clinical progress and collaborations with leading cancer research institutions — Cleveland Clinic and Moffitt Cancer Center "We are pleased to be invited to this ...
Amit Kumar, Ph.D., Chairman and CEO of Anixa Biosciences (NASDAQ:ANIX), joins the RedChip Small Stocks, Big Money™ show with a participant in the company’s Phase 1 breast cancer vaccine trial to ...
ORLANDO, FL / ACCESS Newswire / September 11, 2026 / RedChip Companies will air interviews with Anixa Biosciences Inc. (NASDAQ:ANIX) and Nexalin Technology Inc. (NASDAQ:NXL) on the RedChip Small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results